Acknowledgments
RA, Prostate Cancer, Cancer
PROSTATE CANCER, CANCER
This study was funded in part by the National Cancer Institute (R01CA229354) and the Prostate Cancer Foundation (20CHAL05). Study materials were provided by Novartis Pharmaceuticals and Merck. Philanthropic support was provided by Eugene Daly and Ethel Daly to the University of California, San Francisco Prostate Cancer Program. RA, TH, LF, ME, FF, RB, and DO received research grants from the National Cancer Institute. We thank the patients who participated in this study and all investigators and research support staff.